UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $222,000 | -47.6% | 6,580 | -43.9% | 0.00% | -100.0% |
| Q4 2020 | $424,000 | -65.2% | 11,724 | -62.2% | 0.00% | -75.0% |
| Q3 2019 | $1,220,000 | +159.6% | 31,000 | +55.0% | 0.00% | +100.0% |
| Q1 2018 | $470,000 | +65.5% | 20,000 | -32.4% | 0.00% | +100.0% |
| Q3 2017 | $284,000 | +55.2% | 29,595 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $183,000 | +7.0% | 29,595 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $171,000 | +3.0% | 29,595 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $166,000 | +80.4% | 29,595 | +146.7% | 0.00% | 0.0% |
| Q3 2016 | $92,000 | +4.5% | 11,995 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $88,000 | -69.8% | 11,995 | -51.0% | 0.00% | -50.0% |
| Q1 2016 | $291,000 | -14.2% | 24,495 | +19.5% | 0.00% | -33.3% |
| Q4 2015 | $339,000 | +46.8% | 20,495 | +81.7% | 0.00% | +50.0% |
| Q3 2015 | $231,000 | – | 11,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |